Yervoy and Neuropathies
Result of checking the interaction of drug Yervoy and disease Neuropathies for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Immune-mediated neuropathies, including fatal cases, have occurred with ipilimumab therapy. Ipilimumab must be permanently discontinued in patients with severe neuropathy (interfering with daily activities) such as Guillain-Barré-like syndromes and appropriate measures should be initiated. Withhold ipilimumab dosing in patients with moderate neuropathy (not interfering with daily activities).